DK0670721T3 - Drug for the treatment and prevention of bone and joint diseases - Google Patents
Drug for the treatment and prevention of bone and joint diseasesInfo
- Publication number
- DK0670721T3 DK0670721T3 DK93920843T DK93920843T DK0670721T3 DK 0670721 T3 DK0670721 T3 DK 0670721T3 DK 93920843 T DK93920843 T DK 93920843T DK 93920843 T DK93920843 T DK 93920843T DK 0670721 T3 DK0670721 T3 DK 0670721T3
- Authority
- DK
- Denmark
- Prior art keywords
- bone
- drug
- prevention
- treatment
- joint diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP1993/002668 WO1995008992A1 (en) | 1992-01-13 | 1993-09-30 | Drug for treatment and prophylaxis of bone and joint diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0670721T3 true DK0670721T3 (en) | 2000-03-06 |
Family
ID=8165769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93920843T DK0670721T3 (en) | 1993-09-30 | 1993-09-30 | Drug for the treatment and prevention of bone and joint diseases |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0670721B1 (en) |
AU (1) | AU4819993A (en) |
CH (1) | CH682716A5 (en) |
DE (1) | DE59309732D1 (en) |
DK (1) | DK0670721T3 (en) |
WO (1) | WO1995008992A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH682716A5 (en) * | 1992-01-13 | 1993-11-15 | Christian Fricker | Degenerative bone or joint disease treatment compsn. - contg. benzo-pyrone or dobesilate calcium, esp. for treating osteo-arthrosis or podotrochlosis |
ES2208123A1 (en) * | 2002-11-29 | 2004-06-01 | Laboratorios Del Dr. Esteve, S.A. | Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
DK2468292T3 (en) | 2006-04-27 | 2020-03-23 | Lantmaennen Medical Ab | New peptide with antisecretory activity |
PL2040734T3 (en) * | 2006-04-27 | 2012-04-30 | Lantmaennen As Faktor Ab | Antisecretory protein for use in the treatment of compartment syndrome |
EP2054045B1 (en) * | 2006-08-16 | 2011-05-18 | Action Medicines, S.L. | Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain |
DE502007002101D1 (en) * | 2007-03-12 | 2010-01-07 | Dobavet Gmbh | Medicinal products containing dobesilate calcium for the treatment and prophylaxis of tendon diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60147224A (en) * | 1984-01-10 | 1985-08-03 | ジユゼツペ カネストリ | Polymer dispersant, its production and dispersion containingsaid dispersant |
CH682716A5 (en) * | 1992-01-13 | 1993-11-15 | Christian Fricker | Degenerative bone or joint disease treatment compsn. - contg. benzo-pyrone or dobesilate calcium, esp. for treating osteo-arthrosis or podotrochlosis |
-
1992
- 1992-01-13 CH CH58/92A patent/CH682716A5/en not_active IP Right Cessation
-
1993
- 1993-09-30 DK DK93920843T patent/DK0670721T3/en active
- 1993-09-30 EP EP93920843A patent/EP0670721B1/en not_active Expired - Lifetime
- 1993-09-30 AU AU48199/93A patent/AU4819993A/en not_active Abandoned
- 1993-09-30 WO PCT/EP1993/002668 patent/WO1995008992A1/en active IP Right Grant
- 1993-09-30 DE DE59309732T patent/DE59309732D1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1995008992A1 (en) | 1995-04-06 |
CH682716A5 (en) | 1993-11-15 |
EP0670721B1 (en) | 1999-08-11 |
AU4819993A (en) | 1995-04-18 |
EP0670721A1 (en) | 1995-09-13 |
DE59309732D1 (en) | 1999-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1382340T3 (en) | Therapeutic uses of dehydroepiandrosterone for the treatment of reduced libido and osteoporosis | |
BR9407799A (en) | Composition of matter treatment method and pharmaceutical composition | |
IS5500A (en) | Medicinal preparations for the stimulation and treatment of gastrointestinal disorders and related diseases | |
DK1041990T3 (en) | Composition for the treatment of respiratory and skin diseases with at least one leukotriene antagonist and at least one antihistamine | |
DK0630181T3 (en) | Nutritional product for injured and surgical patients | |
NO933743D0 (en) | PROCEDURE AND SYSTEM FOR IMPLEMENTING ENDOSCOPE SURGERY | |
NO994014L (en) | Arylsulfonamides and analogs thereof and their use in the treatment of neurodegenerative diseases | |
NO20004098L (en) | Methods and preparations for the treatment of macrophage-mediated disorders | |
DE69332732D1 (en) | Pharmaceutical composition and method for the treatment of hyperlipidemia and arteriosclerosis | |
IS4805A (en) | Method of treatment and pharmaceutical composition | |
DE69620691D1 (en) | Therapeutic agent for the treatment of hypercholesterolemia | |
DK1041985T3 (en) | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of prophylactic disorders | |
DK249688A (en) | PHARMACEUTICAL COMBINATION FOR PREVENTION AND TREATMENT OF MALARIA | |
NO983512D0 (en) | Means for the treatment and prevention of AIDS | |
DE69420229D1 (en) | Pharmaceutical composition for the treatment of AIDS | |
NO961226D0 (en) | Compounds for the prevention and treatment of viral-induced tumors | |
DK0670721T3 (en) | Drug for the treatment and prevention of bone and joint diseases | |
NO171798C (en) | PROCEDURE FOR THE TREATMENT OF SINCED BY-PRODUCTS AND WASTE MATERIALS | |
NO932912D0 (en) | PREPARATION AND PROCEDURES FOR GENERATION OF BONE | |
NO20001758D0 (en) | Methods and compositions for the treatment of arthritis | |
NO973193D0 (en) | Collagen-based methods and formulations for the treatment of immune system-mediated diseases | |
NO964330D0 (en) | Pharmaceutical composition for therapeutic treatment of tardive dyskinesia and use thereof | |
FI944687L (en) | Composition for the prevention and treatment of myopia | |
FI961494L (en) | Pharmaceutical compositions and their use, especially for the treatment of neurodegenerative diseases | |
ITMI940199A0 (en) | CATHETER AND PROCEDURE FOR ITS MANUFACTURE |